Home > Balance Sheet > BAFNA PHARMACEUTICALS

BAFNA PHARMACEUTICALS
Contingent Liabilities

    Back to Balance Sheet
AD     Remove this Ad

BAFNA PHARMACEUTICALS Last 5 Year Contingent Liabilities History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
Contingent Liabilities ₹18 Cr₹18 Cr₹10 Cr₹6.17 Cr₹2.00 Cr

What is the latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS ?

The latest Contingent Liabilities ratio of BAFNA PHARMACEUTICALS is ₹18 Cr based on Mar2025 Standalone results.
Year Contingent Liabilities
Mar2025₹18 Cr
Mar2024₹18 Cr
Mar2023₹10 Cr
Mar2022₹6.17 Cr
Mar2021₹2.00 Cr

How is Contingent Liabilities of BAFNA PHARMACEUTICALS Trending?

Years Contingent Liabilities % Change
Mar2025 ₹18 Cr
-0.06
Mar2024 ₹18 Cr
67.43
Mar2023 ₹10 Cr
69.85
Mar2022 ₹6.17 Cr
208.45
Mar2021 ₹2.00 Cr -

Compare Contingent Liabilities of peers of BAFNA PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS ₹281.7 Cr 9.8% 2.5% 56.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,407.0 Cr -2.2% 2.5% 1.7% Stock Analytics
DIVIS LABORATORIES ₹159,596.0 Cr -1.2% -4.5% 5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,619.0 Cr -2.1% -0.2% 36.1% Stock Analytics
DR REDDYS LABORATORIES ₹104,544.0 Cr -2.4% -2.1% 11.5% Stock Analytics
CIPLA ₹98,767.6 Cr -4.6% -8% -16.8% Stock Analytics


BAFNA PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAFNA PHARMACEUTICALS

9.8%

2.5%

56.4%

SENSEX

-3.7%

-13.2%

-2%


You may also like the below Video Courses